Gibson Dunn & Crutcher LLP Advised Gamma Bioscience on the Sale of its Operating Company Astrea Bioseparations in Exchange for Newly Issued Shares in Biotage AB

February 16, 2023

Gibson Dunn & Crutcher LLP advised California-based global sciences platform Gamma Biosciences, formed by global investment firm KKR, on the sale of its operating company Astrea Bioseparations in exchange for newly issued shares in Swedish life sciences company Biotage AB, creating a global chromatography leader. More information can be found in the news announcement.

The Gibson Dunn team representing Gamma was led by partner Wim De Vlieger, with partners Isabel Berger and Chris Haynes, as well as associates Hui Zen Gan, Romain Tourenne, Scarlett Travers, tax partner Benjamin Fryer and associate Bridget English. Partner Lilit Voskanyan also provided assistance on the deal.